The Jikei University School of Medicine · Graduate School of Medicine / Faculty of Medicine · 講師

Research keywordsT cell lymphoma・multiple myeloma・acute myeloid leukemia・stem cell transplant・amyloidosis

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• 同種造血幹細胞移植の再発後、dasatinibの少量投与で分子生物学的寛解を維持しているPh陽性ALLの1例
• NK and T-lymphocyte Kinetics Predict Outcome in Myeloma Patients Treated With Elotuzumab, Lenalidomide Plus Dexamethasone.
• Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.
• MRD陰性多発性骨髄腫患者における継続治療の臨床的意義(Clinical significance of continuous treatment for patients with MRD-negative multiple myeloma)

• 多発性骨髄腫における抗癌剤感受性規定因子“SLFN11”の発現と臨床的意義
• 経時的ペントシジン測定による骨髄腫患者の前向き骨病変管理とADL・QOL調査

• Official profile